Pharmhouse Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +14.0% | -39.8% | -100.0% | +64,938.0% | -26.2% | -36.3% | -68.3% | – | – | – | – | – | – | – | |
| – | +27.2% | -24.6% | -100.0% | +117.6% | +135,406.4% | -53.2% | -76.6% | -79.8% | – | – | – | – | – | – | |
| – | -1.3% | -62.6% | -100.0% | -90.2% | -233,747.1% | – | – | -158.4% | – | – | – | – | – | – | |
| – | +28.5% | -47.1% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -57.9% | – | – | – | – | – | – | – | – | – | +3,703.0% | |
| – | +22.8% | -33.4% | -100.0% | -53.6% | +208,085.1% | -85.8% | -26.3% | -32.7% | +656,759.8% | -95.8% | +16.1% | +97.7% | -11.7% | +2,373.4% | |
| – | – | – | – | -66,735.2% | – | – | – | – | – | – | – | – | – | – | |
| – | +46.3% | +35.4% | – | – | – | -43.6% | -52.5% | +26.6% | – | – | – | +10,516.0% | +48.1% | -70.7% | |
| – | – | – | – | -288,287.9% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +0.0% | – | – | – | – | – | – | – | |
| – | – | – | – | -398.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +33,702.8% | -1,188.3% | – | – | – | – | – | – | – | – | – |
Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.